As of Jul 22
| +0.15 / +0.38%|
The 1 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 44.00, with a high estimate of 44.00 and a low estimate of 44.00. The median estimate represents a +11.53% increase from the last price of 39.45.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.